Pricing Log in Create free account

Dianthus Therapeutics, Inc. (DNTH) vs Veradermics Incorporated (MANE)

Dianthus Therapeutics, Inc. and Veradermics Incorporated are both Biotechnology companies. Veradermics Incorporated is the larger, with a market value of $5.4B against $4.6B — 1.2× the size. Veradermics Incorporated has the higher net margin (0.00% vs −7,436.5%) and the higher return on invested capital (0.00% vs −36.6%). Across the 12 metrics below, Veradermics Incorporated leads on 9 and Dianthus Therapeutics, Inc. on 3.

Valuation

Metric DNTH MANE Biotechnology median
P/E n/m n/m 10.60
P/S 1,823.40 n/m 9.40
P/B 3.99 6.87 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1,515.16 n/m 9.02
Earnings yield (4.62%) (33.20%) (32.88%)
Free cash flow yield (3.55%) (2.20%) (23.13%)

Profitability

Metric DNTH MANE Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (8,683.89%) 0.00% 0.00%
Net margin (7,436.50%) 0.00% 0.00%
Free cash flow margin (6,469.87%) 0.00% 0.00%
Return on equity (22.61%) 0.00% (51.96%)
Return on assets (21.81%) (20.86%) (46.06%)
Return on invested capital (36.55%) 0.00% 0.00%

Growth

Metric DNTH MANE Biotechnology median
Revenue growth (TTM) (11.70%) — 6.76%
EPS growth (last fiscal year) (64.71%) (211.38%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DNTH MANE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 30.02 70.53 4.97
Net debt to EBITDA 2.20 1.96 1.01

Dividend

Metric DNTH MANE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DNTH MANE Biotechnology median
Market cap 4.64b 5.37b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack